Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Repressor Proteins | 4 | 2019 | 760 | 0.970 |
Why?
|
| Cavernous Sinus | 1 | 2023 | 23 | 0.790 |
Why?
|
| Hemangioma, Cavernous | 1 | 2023 | 19 | 0.790 |
Why?
|
| Hemangioma | 1 | 2023 | 86 | 0.740 |
Why?
|
| Inclusion Bodies | 1 | 2021 | 38 | 0.670 |
Why?
|
| Ataxin-1 | 4 | 2018 | 168 | 0.650 |
Why?
|
| Molecular Imaging | 1 | 2020 | 58 | 0.610 |
Why?
|
| Hepatocytes | 1 | 2021 | 232 | 0.600 |
Why?
|
| Intestinal Neoplasms | 1 | 2019 | 36 | 0.590 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2021 | 157 | 0.570 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 357 | 0.560 |
Why?
|
| Neuroendocrine Tumors | 1 | 2019 | 70 | 0.550 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2020 | 223 | 0.540 |
Why?
|
| Meningioma | 3 | 2026 | 151 | 0.520 |
Why?
|
| Transplant Recipients | 1 | 2019 | 235 | 0.510 |
Why?
|
| Meningeal Neoplasms | 3 | 2026 | 220 | 0.500 |
Why?
|
| Graft Rejection | 2 | 2020 | 552 | 0.470 |
Why?
|
| Kidney Neoplasms | 1 | 2020 | 421 | 0.470 |
Why?
|
| Biomarkers, Tumor | 2 | 2026 | 1586 | 0.460 |
Why?
|
| Nuclear Proteins | 3 | 2017 | 1211 | 0.450 |
Why?
|
| Liver | 2 | 2021 | 1796 | 0.440 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 280 | 0.400 |
Why?
|
| Liver Transplantation | 2 | 2020 | 1147 | 0.400 |
Why?
|
| Stomach Neoplasms | 1 | 2019 | 572 | 0.390 |
Why?
|
| Pancreatic Neoplasms | 1 | 2019 | 740 | 0.380 |
Why?
|
| Cerebellum | 3 | 2025 | 441 | 0.370 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 982 | 0.350 |
Why?
|
| Autism Spectrum Disorder | 1 | 2017 | 450 | 0.340 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 1373 | 0.320 |
Why?
|
| Biopsy | 4 | 2021 | 1239 | 0.300 |
Why?
|
| Nerve Tissue Proteins | 4 | 2017 | 1075 | 0.290 |
Why?
|
| Glioblastoma | 2 | 2022 | 371 | 0.270 |
Why?
|
| Purkinje Cells | 2 | 2025 | 164 | 0.230 |
Why?
|
| Neurofibromin 2 | 1 | 2025 | 10 | 0.230 |
Why?
|
| Radiation Tolerance | 1 | 2025 | 61 | 0.220 |
Why?
|
| B7-H1 Antigen | 1 | 2026 | 136 | 0.220 |
Why?
|
| Spinocerebellar Ataxias | 2 | 2018 | 154 | 0.210 |
Why?
|
| Loss of Function Mutation | 1 | 2025 | 177 | 0.200 |
Why?
|
| Mycorrhizae | 1 | 2022 | 1 | 0.180 |
Why?
|
| Orchidaceae | 1 | 2022 | 2 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 3763 | 0.170 |
Why?
|
| Aged | 6 | 2026 | 21025 | 0.170 |
Why?
|
| Cyanamide | 1 | 2021 | 2 | 0.170 |
Why?
|
| Male | 12 | 2026 | 64957 | 0.170 |
Why?
|
| Sinusitis | 1 | 2022 | 118 | 0.170 |
Why?
|
| Glycogen Storage Disease | 1 | 2021 | 8 | 0.170 |
Why?
|
| Glycogen | 1 | 2021 | 50 | 0.170 |
Why?
|
| Polypharmacy | 1 | 2021 | 36 | 0.170 |
Why?
|
| Microscopy, Electron | 1 | 2021 | 305 | 0.160 |
Why?
|
| Humans | 19 | 2026 | 131163 | 0.160 |
Why?
|
| Neoplasm Metastasis | 2 | 2021 | 713 | 0.160 |
Why?
|
| Cytoplasm | 1 | 2021 | 249 | 0.160 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 6797 | 0.160 |
Why?
|
| Female | 11 | 2026 | 70963 | 0.150 |
Why?
|
| Demyelinating Diseases | 1 | 2020 | 68 | 0.150 |
Why?
|
| Hepatitis B, Chronic | 1 | 2021 | 84 | 0.150 |
Why?
|
| Middle Aged | 6 | 2026 | 28601 | 0.150 |
Why?
|
| Hyperplasia | 1 | 2019 | 191 | 0.140 |
Why?
|
| Neoplasm Grading | 3 | 2026 | 274 | 0.140 |
Why?
|
| Re-Irradiation | 1 | 2018 | 5 | 0.140 |
Why?
|
| Adult | 6 | 2025 | 31282 | 0.140 |
Why?
|
| Drosophila melanogaster | 2 | 2014 | 789 | 0.140 |
Why?
|
| Aging | 1 | 2025 | 1242 | 0.140 |
Why?
|
| Glioma | 1 | 2022 | 494 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2021 | 502 | 0.130 |
Why?
|
| Age of Onset | 1 | 2019 | 592 | 0.130 |
Why?
|
| Dietary Supplements | 1 | 2021 | 448 | 0.130 |
Why?
|
| Gain of Function Mutation | 1 | 2018 | 115 | 0.130 |
Why?
|
| Brain Diseases | 1 | 2020 | 299 | 0.130 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 663 | 0.120 |
Why?
|
| ras Proteins | 2 | 2018 | 140 | 0.120 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 91 | 0.120 |
Why?
|
| RNA Splicing Factors | 1 | 2016 | 51 | 0.120 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 274 | 0.120 |
Why?
|
| Frontotemporal Dementia | 1 | 2016 | 56 | 0.120 |
Why?
|
| Nerve Degeneration | 1 | 2016 | 128 | 0.120 |
Why?
|
| Interpersonal Relations | 1 | 2017 | 223 | 0.110 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 161 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1882 | 0.110 |
Why?
|
| Retrospective Studies | 4 | 2022 | 17753 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 2085 | 0.100 |
Why?
|
| rab1 GTP-Binding Proteins | 1 | 2014 | 3 | 0.100 |
Why?
|
| Dimethylallyltranstransferase | 1 | 2014 | 4 | 0.100 |
Why?
|
| Child, Preschool | 2 | 2021 | 15110 | 0.100 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2014 | 52 | 0.100 |
Why?
|
| Protein Subunits | 1 | 2014 | 157 | 0.100 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2013 | 37 | 0.100 |
Why?
|
| Mice | 6 | 2025 | 18301 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 183 | 0.090 |
Why?
|
| Receptors, Notch | 1 | 2014 | 197 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 1306 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 359 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2020 | 5063 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2018 | 1928 | 0.080 |
Why?
|
| Intellectual Disability | 1 | 2017 | 1089 | 0.080 |
Why?
|
| Animals | 7 | 2025 | 33912 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2013 | 1064 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 1722 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 1939 | 0.070 |
Why?
|
| Drosophila Proteins | 1 | 2014 | 718 | 0.070 |
Why?
|
| Phenotype | 1 | 2017 | 4497 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2026 | 116 | 0.060 |
Why?
|
| Necrosis | 1 | 2025 | 192 | 0.050 |
Why?
|
| Infant | 1 | 2019 | 13352 | 0.050 |
Why?
|
| Ataxins | 2 | 2013 | 109 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2025 | 4738 | 0.050 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2022 | 26 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2025 | 3748 | 0.050 |
Why?
|
| Trehalase | 1 | 2022 | 2 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2018 | 2885 | 0.050 |
Why?
|
| Autopsy | 1 | 2022 | 111 | 0.050 |
Why?
|
| Trehalose | 1 | 2022 | 21 | 0.050 |
Why?
|
| Child | 2 | 2020 | 26341 | 0.040 |
Why?
|
| Symbiosis | 1 | 2022 | 70 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2022 | 263 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2022 | 248 | 0.040 |
Why?
|
| Adolescent | 1 | 2019 | 20987 | 0.040 |
Why?
|
| Cause of Death | 1 | 2022 | 506 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2026 | 1272 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2020 | 670 | 0.040 |
Why?
|
| Graft Survival | 1 | 2020 | 465 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 2022 | 345 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 633 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2025 | 2026 | 0.030 |
Why?
|
| Receptor, Notch1 | 1 | 2018 | 78 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2018 | 351 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 713 | 0.030 |
Why?
|
| Radiosurgery | 1 | 2018 | 148 | 0.030 |
Why?
|
| Mutation | 2 | 2022 | 6099 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 188 | 0.030 |
Why?
|
| Prognosis | 1 | 2026 | 4886 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2021 | 768 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2016 | 235 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 1483 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 4697 | 0.030 |
Why?
|
| Recurrence | 1 | 2018 | 1489 | 0.030 |
Why?
|
| Protein Prenylation | 1 | 2014 | 8 | 0.030 |
Why?
|
| Exons | 1 | 2016 | 759 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2018 | 4686 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 1621 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2013 | 92 | 0.020 |
Why?
|
| Dimerization | 1 | 2013 | 137 | 0.020 |
Why?
|
| Protein Stability | 1 | 2013 | 165 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 533 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 2326 | 0.020 |
Why?
|
| Inflammation | 1 | 2020 | 1489 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 291 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 950 | 0.020 |
Why?
|
| Transgenes | 1 | 2013 | 316 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2014 | 346 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 300 | 0.020 |
Why?
|
| Computational Biology | 1 | 2016 | 862 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 645 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 588 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 5196 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 386 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2018 | 3819 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2013 | 1571 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 2395 | 0.020 |
Why?
|
| Protein Binding | 1 | 2013 | 1652 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3464 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2014 | 1590 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 2323 | 0.010 |
Why?
|